NICE

News

Bayer's Kerendia on course for NHS use in heart failure

Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.

News

NICE aims to cut funding for Amgen lung cancer drug Lumykras

Amgen's Lumykras will no longer be funded by the Cancer Drugs Fund for KRAS-mutated lung cancer, says NHS reimbursement authority NICE.

News

NICE backs NHS use of non-invasive endometriosis tests

Women with endometriosis in England could be offered simple non-invasive tests for diagnosis of their condition, rather than a surgical procedure.

News

Two women sit side by side in support of each other, one in a white coat and beret, the other in red

NICE guidance calls for quicker diagnosis of PMOS

Women with polyendocrine metabolic ovarian syndrome (PMOS) should be diagnosed sooner and be offered an annual review, according to new NICE guidance.

News

NICE delivers more good news for cervical cancer patients

Hundreds of women with locally advanced cervical cancer are to be offered MSD's Keytruda on the NHS in England, thanks to new NICE guidance.

News

NICE says Libtayo can be used for advanced cervical cancer

New NICE guidance means that around 90 UK women with cervical cancer should be eligible for treatment with Regeneron's Libtayo each year.

Bayer's Kerendia on course for NHS use in heart failure

NICE aims to cut funding for Amgen lung cancer drug Lumykras

NICE backs NHS use of non-invasive endometriosis tests

NICE guidance calls for quicker diagnosis of PMOS

NICE delivers more good news for cervical cancer patients

NICE says Libtayo can be used for advanced cervical cancer

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

NICE

Editor's Picks